MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mao.0000000000001311

Медицинская библиотека · Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2017

Intratympanic Triamcinolone and Dexamethasone in the Treatment of Ménière's Syndrome.

Jumaily Mejd, Faraji Farhoud, Mikulec Anthony A

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To describe the safety and potential efficacy of intratympanic administration of triamcinolone (40 mg/mL) in the treatment of unilateral Ménière's syndrome.

STUDY

DESIGN

Single-institution retrospective analysis.

SETTING

Tertiary referral neurotology clinic.

PATIENTS: Eighteen patients diagnosed with unilateral Ménière's syndrome with vertigo refractory to medical management.

INTERVENTION(S): Intratympanic injection of triamcinolone or dexamethasone.

OUTCOME MEASURE(S): Kaplan-Meier analysis was implemented to determine the rate of successful vertigo control. Responders were defined as patients who achieved sufficient vertigo control to decline ablative therapy. Nonresponders were defined as those who did not achieve satisfactory vertigo control and required ablative or surgical therapy. Pre- and posttreatment audiogram data was used to evaluate changes in hearing. Patient follow-up data was assessed for complications potentially resulting from intratympanic therapy.

RESULTS

No patient experienced profound hearing loss or other serious adverse events as a result of intratympanic triamcinolone therapy. Tympanic membrane perforation occurred in three (18%) patients, all of whom had received three or more previous intratympanic injections. Satisfactory vertigo control with intratympanic triamcinolone therapy was achieved in 14 (78%) of 18 subjects.

CONCLUSION

Our results suggest that intratympanic triamcinolone therapy on an as-needed basis is a safe and potentially effective procedure for vertigo control in patients with Ménière's syndrome. These findings warrant the implementation of prospective, controlled trials to investigate its safety and efficacy further.

Для цитирования: Jumaily Mejd, Faraji Farhoud, Mikulec Anthony A. Intratympanic Triamcinolone and Dexamethasone in the Treatment of Ménière's Syndrome.. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2017. DOI: 10.1097/mao.0000000000001311.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.